Regadenoson not checked

Astellas · CVT 3146

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 1/2 trial completes
Trials
2 active
4 in total · 2 in the EU

What this is

How it works
Adenosine Receptor Agonist FDA class
How it’s given
“Regadenoson (Rapiscan®): Single i.v. bolus dose in stress rest CMR”In the company’s words, NCT04604782 on ClinicalTrials.gov
Tested for
Myocardial Ischemia, Coronary Artery Disease
Main trialPhase 1/2
“This is a multi-centre, open-label, single-dose safety, tolerability and PK-pharmacodynamics (PD) study of the vasodilator regadenoson in 3 paediatric age groups for whom a pharmacologic stress perfusion CMR test is clinically indicated; adolescents aged 12 to \<18 years (Cohort A), children aged 2 to \<12 years (Cohort B), and infants aged 1 to \<24 months and who weigh at least 3 kg (Cohort C). Regadenoson will be used as the pharmacologic stress agent in this study with MPI serving as both surrogate pharmacodynamic marker of the agent (MPR, MBF) and a clinically evaluable examination for…”In the company’s words, NCT04604782 on ClinicalTrials.gov
Other names
Lexiscan · CVT 3146

Other drugs for Myocardial Ischemia

All 43 drugs for Myocardial Ischemia

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 1/2Recruiting Dec 2026 A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
Phase 3Completed 15 Jul 2010 Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Phase 2Completed 2 Jul 2012 A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
Phase 4Authorised not given Evaluation of patients with total coronary occlusions with multimodality image.
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Regadenoson

Following is part of Solo: you see every change to Regadenoson the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in